Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi S Taatjes-Sommer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 18, 2009
Augmentation of megakaryocyte expression of FcgammaRIIa by interferon gammaDavid J Schneider, Heidi S Taatjes-Sommer
Journal of Cardiovascular Pharmacology|March 3, 2021
Influence of Lipid Excipients on Platelet Function and the Pharmacodynamic Effects of AspirinDavid J Schneider, Heidi S Taatjes-Sommer, Jayne Prats, et al.
Thrombosis Research|August 7, 2007
Contributions of young platelets and of previously activated platelets to platelet reactivity in patients with coronary artery diseaseDavid J Schneider, Chris E Holmes, Heidi S Taatjes-Sommer, et al.
The American Journal of Cardiology|December 30, 2019
Assessment of Cardiovascular Risk by the Combination of Clinical Risk Scores Plus Platelet Expression of FcγRIIaDavid J Schneider, Sean R McMahon, Gregory L Ehle, et al.
Journal of Thrombosis and Thrombolysis|April 11, 2019
Variation in platelet expression of FcγRIIa after myocardial infarctionSean R McMahon, Sreedivya Chava, Heidi S Taatjes-Sommer, et al.
Bioanalysis|September 4, 2024
Assessing prognosis by quantifying FcγRIIa on fixed plateletsDavid J Schneider, Heidi S Taatjes-Sommer, Peter M DiBattiste, et al.
Journal of Thrombosis and Thrombolysis|May 18, 2026
Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancerChris E Holmes, George A Davis, Heidi S Taatjes-Sommer, et al.
Journal of Thrombosis and Thrombolysis|August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover studyFrancesco Franchi, David J Schneider, Jayne Prats, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Platelet FcγRIIa Expression in Ischemic Stroke: A Marker of Increased Platelet ReactivityDavid J Schneider, Tristan Honda, Edward Feldmann, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Arteriosclerosis, Thrombosis, and Vascular Biology|April 18, 2009
Augmentation of megakaryocyte expression of FcgammaRIIa by interferon gammaDavid J Schneider, Heidi S Taatjes-Sommer
Journal of Cardiovascular Pharmacology|March 3, 2021
Influence of Lipid Excipients on Platelet Function and the Pharmacodynamic Effects of AspirinDavid J Schneider, Heidi S Taatjes-Sommer, Jayne Prats, et al.
Thrombosis Research|August 7, 2007
Contributions of young platelets and of previously activated platelets to platelet reactivity in patients with coronary artery diseaseDavid J Schneider, Chris E Holmes, Heidi S Taatjes-Sommer, et al.
The American Journal of Cardiology|December 30, 2019
Assessment of Cardiovascular Risk by the Combination of Clinical Risk Scores Plus Platelet Expression of FcγRIIaDavid J Schneider, Sean R McMahon, Gregory L Ehle, et al.
Journal of Thrombosis and Thrombolysis|April 11, 2019
Variation in platelet expression of FcγRIIa after myocardial infarctionSean R McMahon, Sreedivya Chava, Heidi S Taatjes-Sommer, et al.
Bioanalysis|September 4, 2024
Assessing prognosis by quantifying FcγRIIa on fixed plateletsDavid J Schneider, Heidi S Taatjes-Sommer, Peter M DiBattiste, et al.
Journal of Thrombosis and Thrombolysis|May 18, 2026
Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancerChris E Holmes, George A Davis, Heidi S Taatjes-Sommer, et al.
Journal of Thrombosis and Thrombolysis|August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover studyFrancesco Franchi, David J Schneider, Jayne Prats, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Platelet FcγRIIa Expression in Ischemic Stroke: A Marker of Increased Platelet ReactivityDavid J Schneider, Tristan Honda, Edward Feldmann, et al.
Pageof 1